Wei Dong Wang
Founder at REMEGEN CO., LTD.
Net worth: 43 M $ as of 2024-03-30
Profile
Founder of RemeGen Co., Ltd. and Yantai Rongchang Pharmaceutical Co. Ltd., Weidong Wang presently occupies the position of Chairman at Yantai Rongchang Pharmaceutical Co. Ltd. and Chairman at RemeGen Co., Ltd. He received an undergraduate degree from Harbin University of Commerce.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
REMEGEN CO. LTD. CLASS A
2.57% | 2022-12-27 | 4,111,338 ( 2.57% ) | 31 M $ | 2024-03-30 |
REMEGEN CO. LTD. CLASS H
1.89% | 2023-09-30 | 3,584,541 ( 1.89% ) | 12 M $ | 2024-03-30 |
Wei Dong Wang active positions
Companies | Position | Start |
---|---|---|
REMEGEN CO., LTD. | Founder | 2008-07-03 |
Yantai Rongchang Pharmaceutical Co. Ltd. | Founder | 1993-02-28 |
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Director/Board Member | 2013-06-24 |
Training of Wei Dong Wang
Harbin University of Commerce | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REMEGEN CO., LTD. | Health Technology |
Private companies | 2 |
---|---|
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
Yantai Rongchang Pharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Wei Dong Wang